All In Biotech

Drug Trial Radar · NCT06733298

A Study Investigating [14C]-Labeled RO7269162 in Healthy Male Participants

Open-Label, Non-Randomized Study Investigating the Excretion Balance, Pharmacokinetics, and Metabolism of a Single Oral Dose of [14C]-Labeled RO7269162 in Healthy Male Participants

Last checked: Nov 19, 2026Latest source record: Feb 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

8

Actual

Start

Jan 8, 2025

Primary completion

Jan 29, 2025

Study completion Jan 29, 2025

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Dec 13, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 35 years, up to 64 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will investigate how RO7269162 labeled with a carbon tracer (\[14C\]) is absorbed, metabolized, and eliminated by the body after a single dose in healthy male volunteers.

Conditions

  • Healthy Volunteers

Interventions

  • [ 14C]-labeled RO7269162Drug

    Participants will receive one oral dose of \[14C\]-labeled RO7269162.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. [14C] recovery in urineTime frame: Up to Day 22 or Day 37
  2. [14C] recovery in fecesTime frame: Up to Day 22 or Day 37
  3. Concentration of [14C] in whole bloodTime frame: Up to Day 22 or Day 37
  4. Plasma concentration of [14C]Time frame: Up to Day 22 or Day 37
  5. Plasma concentration of RO7269162Time frame: Up to Day 22 or Day 37
  6. Amount of RO7269162 excreted in urineTime frame: Up to Day 22 or Day 37

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • ICON Health sciences research center

    Groningen, Netherlands

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.